Grove Bank & Trust’s Core Laboratories CLB Stock Holding History

Grove Bank & Trust’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,214	Closed	-$70.9K	–	650
2023 Q1	$70.9K	Buy	3,214 +132	+4%	+$3.09K	0.02%	332
2022 Q4	$62K	Buy	+3,082	New	+$59.7K	0.01%	348
2018 Q1	–	Sell	-87	Closed	-$10K	–	216
2017 Q4	$10K	Hold	87	–	–	﹤0.01%	440
2017 Q3	$9K	Buy	+87	New	+$8.43K	﹤0.01%	471

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Grove Bank & Trust's CLB Position: Q2 2023 in Review

Grove Bank & Trust sold out of Core Laboratories (CLB) in Q2 2023, closing a stake of 3,214 shares — an estimated $70.9K sold.

Grove Bank & Trust first reported a position in CLB in Q3 2017 and held it in 4 quarters. The position peaked at $70.9K in Q1 2023. 164 funds tracked by Wall St. Rank hold CLB as of Q2 2023.

Grove Bank & Trust reported no remaining Core Laboratories position as of Q2 2023 after selling out during the quarter.
Grove Bank & Trust sold 3,214 Core Laboratories shares in Q2 2023, an estimated $70.9K.
Grove Bank & Trust first reported a position in Core Laboratories in Q3 2017 and held it in 4 quarters.
Grove Bank & Trust's Core Laboratories position peaked at $70.9K in Q1 2023.
164 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2023.

Based on Grove Bank & Trust's 13F filing for Q2 2023, filed 27 Jul 2023.